查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
虚拟实境暴露疗法市场：2023年至2028年预测
市场调查报告书
商品编码
1410178

虚拟实境暴露疗法市场：2023年至2028年预测

Virtual Reality Exposure Therapy Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

虚拟实境暴露疗法市场预计在预测期内复合年增长率为 38.53%。

虚拟实境暴露疗法（VRET）市场是心理健康疗法中改变游戏规则的部分，它使用尖端的虚拟实境（VR）技术来治疗各种焦虑症和恐惧症。 VRET 提供了一个安全、受控的环境，让患者可以透过逐渐、反覆接触引起焦虑的刺激来控制焦虑。 VRET 透过让患者沉浸在虚拟环境中来模拟现实生活环境，使治疗师能够以受控和监督的方式指导客户完成治疗课程。这种身临其境型和参与式的方法已被证明有助于治疗创伤后压力症候群、社交焦虑和特定恐惧症疾病。随着心理健康专业人士和患者接受这种新颖且有前景的治疗方法，虚拟实境暴露疗法市场可能会显着成长。

虚拟实境技术的进步正在推动虚拟实境暴露疗法市场的成长。

虚拟实境 (VR) 技术的进步极大地改善了虚拟实境暴露疗法 (VRET) 体验，并推动了心理健康治疗的创新。 VR 技术的发展可以提供高度沉浸式和真实的体验，给患者一种临场感和参与感。透过解析度、图形和运动追踪功能的改进，可以实现更真实和动态的虚拟世界。这些进步使治疗师能够创建更接近现实生活情况的客製化设置，从而使他们能够提供个人化的暴露治疗。此外，使用者友好且易于使用的 VR 设备的开发扩大了可以使用 VRET 的患者范围，使其在治疗环境中更容易使用。随着 VR 技术的进步，它有可能透过提供更有效、更有前景的治疗方法来改变精神健康保健领域。

在虚拟实境暴露疗法市场中，人们对非侵入性治疗方法的认识和采用不断增加。

对非侵入性治疗方法的日益接受和理解正在显着推动虚拟实境暴露疗法（VRET）市场的成长。非侵入性治疗在寻求替代治疗的人中越来越受欢迎，因为它们不需要侵入性手术或药物，并且可以提供优异的效果。 VRET顺应了这一趋势，透过身临其境型虚拟体验提供了一种非侵入性的方法来治疗焦虑症和恐惧症。随着心理健康专业人员和患者越来越意识到非侵入性治疗的好处，对 VRET 的需求正在增加。其安全性、个体化方法以及将有害副作用降至最低的能力使这种治疗成为现代精神健康保健的流行选择。

个体化和标靶化的治疗方法将推动虚拟实境暴露疗法市场规模。

个人化和量身定制的治疗技术正在推动虚拟实境暴露疗法（VRET）市场的发展。 VRET 让治疗师根据特定患者的恐惧和焦虑来设计客製化的虚拟情境。 VRET 透过个人化虚拟体验提供高度个人化的治疗方法，确保患者在受控和支持的环境中面对触发因素。这种程度的定制使治疗师能够解决每个患者的个人需求和障碍，从而获得更有效和成功的结果。由于VRET可以专注于特定的恐惧，因此它已成为提高治疗效果、更准确地治疗许多焦虑症和恐惧症以及提高患者满意度的有用工具。

北美是虚拟实境暴露疗法市场的领导者。

北美是虚拟实境暴露疗法（VRET）市场的领导者。该地区处于主导地位的原因有很多，包括现代化的医疗基础设施、心理健康问题的高发生率以及虚拟实境技术在治疗环境中的早期使用。几家知名公司和新兴企业正在北美提供 VRET 解决方案，支援创新并推动虚拟实境暴露治疗市场的成长。此外，该地区的支持性法律规范以及人们对 VRET 在治疗焦虑和恐惧症方面的益处的了解不断增加，正在推动市场占有率。随着 VRET 在世界各地的普及，北美仍然处于其采用和发展的最前沿。

虚拟实境暴露疗法在虚拟实境暴露疗法市场的临床环境中的整合。

虚拟实境暴露疗法（VRET）的临床整合彻底改变了心理健康疗法。 VRET 被治疗师无缝集成，作为补充标准治疗方法的宝贵工具。在受控情况下，使用身临其境型虚拟世界可以系统地对引起焦虑的刺激脱敏。 VRET 使治疗师能够更快地实施暴露治疗，同时准确监测患者的进展。透过模拟现实生活中的情况，患者可以在安全的环境中面对焦虑，从而减少迴避行为并改善应对策略。此外，VRET可用于治疗各种焦虑症和恐惧症，并提高其在治疗环境中的适应性和有效性。随着越来越多的心理健康专业人士接受 VRET，VRET 对心理健康护理的革命性影响将继续增长，从而为患者带来更大的治疗益处。

主要进展：

2022年5月，虚拟实境先驱OxfordVR宣布完成1,250万美元的A轮资金筹措，这是英国和欧洲VR治疗领域最大的资金筹措。 2022 年 12 月，两家虚拟实境心理和行为健康公司 BehaVR 和 OxfordVR 宣布获得 1,300 万美元的 B 轮融资，由 Optum Ventures 和 Oxford Science Enterprises主导，Confluence Health、Accenture Ventures、Chrysalis Ventures 和Thornton Capital 跟投。本轮融资后，我们此时宣布合併。

公司产品

  • 虚拟实境分析平台： CognitiveVR 可能会提供一个完整的分析平台，让心理健康医生和研究人员收集和分析 VRET 会话的资料。在暴露治疗期间，该平台可以监测患者的反应、行为和进展。
  • 身临其境型虚拟环境： OxfordVR 计画提供一个真实的虚拟环境库，反映现实生活场景，帮助患者面对并逐步克服他们特定的恐惧症和焦虑症。
  • 虚拟实境硬体：我们提供一系列虚拟实境技术，例如耳机和运动追踪控制器，为患者提供高度逼真且引人入胜的 VRET 体验。
  • LimbixVR应用程式： Limbix有望为辐射暴露治疗提供使用者友好且有吸引力的虚拟实境软体。该应用程式提供了一个沉浸式且可配置的场景库，这些场景反映了现实生活中的情况，并有可能允许治疗师为患者建立客製化的暴露课程。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 资讯来源
  • 研究设计

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 业内竞争对手之间的对抗关係
  • 产业价值链分析

第五章虚拟实境暴露治疗市场：按组成部分

  • 介绍
  • 硬体
  • 软体

第六章虚拟实境暴露治疗市场：依应用分类

  • 介绍
  • 焦虑症
  • 创伤后压力症候群（PTSD）
  • 恐惧症和特定的恐惧
  • 恐慌症
  • 强迫性精神官能症(OCD)
  • 其他的

第七章虚拟实境暴露治疗市场：依类型

  • 介绍
  • 监控和健康追踪
  • 疾病管理
  • 远距医疗和远端医疗
  • 药物医嘱遵从性
  • 健身和营养
  • 女性健康
  • 其他的

第八章虚拟实境暴露治疗市场：依最终用户分类

  • 介绍
  • 医院和诊所
  • 心理健康中心
  • 研究机构
  • 其他的

第九章虚拟实境暴露治疗市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 台湾
    • 其他的

第十章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第十一章 公司简介

  • VIRTUALLY BETTER, INC.
  • LIMBIX INC.
  • PSIOUS
  • OXFORD VR
  • APPLIEDVR, INC.
  • VIRTUAL REALITY MEDICAL CENTER
  • VIRTUAL REHAB
  • BRAVEMIND（DEVELOPED BY USC INSTITUTE FOR CREATIVE TECHNOLOGIES）
  • XRHEALTH（FORMERLY KNOWN AS VRHEALTH）
  • COGNIFIT
简介目录
Product Code: KSI061615860

The virtual reality exposure therapy market is expected to grow at a CAGR of 38.53% over the forecast period.

The virtual reality exposure therapy (VRET) market is a game-changing section of mental health therapy that uses cutting-edge virtual reality (VR) technology to treat a variety of anxiety disorders and phobias. VRET provides a secure and controlled setting in which patients may address their anxieties by gradually and repeatedly exposing themselves to anxiety-inducing stimuli. VRET simulates real-life settings by immersing patients in virtual environments, allowing therapists to guide clients through therapy sessions in a controlled and supervised way. This immersive and participatory method has been shown to be beneficial in treating illnesses such as PTSD, social anxiety, and particular phobias. As mental health professionals and patients embrace this novel and promising therapy modality, the virtual reality exposure therapy market is likely to rise significantly.

Advancements in Virtual Reality Technology Enhances the Virtual Reality Exposure Therapy Market Growth.

Virtual reality (VR) technological advancements have dramatically improved the virtual reality exposure therapy (VRET) experience, propelling innovation in mental health treatment. VR technology has advanced to provide very immersive and realistic experiences, giving patients a greater sensation of presence and involvement. More lifelike and dynamic virtual worlds are made possible by improved resolution, graphics, and motion tracking capabilities. These advances enable therapists to build customized settings that closely resemble real-life conditions, allowing for individualized exposure treatment. Furthermore, the development of user-friendly and accessible VR equipment has extended VRET's accessibility to a larger patient group, making it more accessible in therapeutic settings. As VR technology advances, it has the potential to transform the area of mental health care by delivering more effective and promising therapeutic methods.

Growing Awareness and Adoption of Non-Invasive Therapies in Virtual Reality Exposure Therapy Market.

The increased acceptance and understanding of non-invasive therapies have considerably aided the growth of the virtual reality exposure therapy (VRET) market. Non-invasive treatments have gained popularity as people seek alternative treatment alternatives owing to their potential to give excellent outcomes without the need for intrusive procedures or drugs. VRET is in line with this trend, providing a non-invasive way to treat anxiety disorders and phobias via immersive virtual experiences. The demand for VRET has risen as mental health professionals and patients become more aware of the benefits of non-invasive therapy. Because of its safety, personalised approach, and capacity to minimise harmful negative effects, the treatment has become a popular option in modern mental health care.

Personalized and Targeted Treatment Approaches Boost the Virtual Reality Exposure Therapy Market Size.

Personalised and tailored treatment techniques are propelling the virtual reality exposure therapy (VRET) market forward. VRET enables therapists to design customised virtual situations based on particular patients' fears and anxieties. VRET delivers a highly personalised therapy approach by personalising the virtual experiences, ensuring that patients confront their triggers in a controlled and supportive setting. This level of customisation allows therapists to address the individual requirements and obstacles of each patient, resulting in more effective and successful outcomes. The capacity to concentrate and focus on specific fears improves the efficacy of the therapy, making VRET a helpful tool in treating numerous anxiety disorders and phobias with more accuracy and patient satisfaction.

North America is the Market Leader in the Virtual Reality Exposure Therapy Market.

North America is the market leader in the virtual reality exposure therapy (VRET) market. Several reasons contribute to the region's leadership, including modern healthcare infrastructure, a high prevalence of mental health issues, and early use of virtual reality technology in treatment settings. Several prominent firms and startups provide VRET solutions in North America, supporting innovation and driving virtual reality exposure therapy market growth. Furthermore, the region's supportive regulatory framework and growing knowledge of the benefits of VRET for anxiety and phobia therapy have boosted its market presence. As VRET gaining traction across the world, North America continues to be at the forefront of its adoption and development.

Integration of Virtual Reality Exposure Therapy in Clinical Practice in Virtual Reality Exposure Therapy Market.

Virtual reality exposure therapy (VRET) integration in clinical practice has transformed mental health therapy. VRET is smoothly integrated by therapists as a beneficial tool to supplement standard therapeutic approaches. In a controlled context, the use of immersive virtual worlds allows for systematic desensitisation to anxiety-inducing stimuli. VRET allows therapists to give exposure treatment more swiftly while precisely monitoring patients' progress. Patients confront their concerns in a secure environment by simulating real-life circumstances, resulting in fewer avoidance behaviours and improved coping methods. Furthermore, VRET may be modified to treat a wide range of anxiety disorders and phobias, increasing its adaptability and efficacy in therapeutic settings. VRET's revolutionary influence on mental health care continues to grow as more mental health practitioners incorporate it, resulting in greater treatment results for patients.

Key Developments:

  • In May 2022, Oxford VR, a virtual reality pioneer, announced the completion of a $12.5 million Series A fundraising round, the largest investment funding for VR therapy in the UK and Europe.
  • In December 2022, BehaVR and OxfordVR, two virtual reality mental and behavioural health companies, announced their merger today, backed by a $13 million Series B round led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures, and Thornton Capital.

Company Products:

  • Virtual Reality Analytics Platform: CognitiveVR will most likely provide a full analytics platform that allows mental health doctors and researchers to collect and analyse data from VRET sessions. During exposure therapy, this platform enables the monitoring of patient responses, behaviours, and progress.
  • Immersive Virtual Environments: Oxford VR is anticipated to provide a library of realistic virtual settings that mirror real-life scenarios, allowing patients to confront and gradually overcome specific phobias and anxieties.
  • Virtual Reality Hardware: The business may provide a suite of virtual reality technology, like as headsets and motion-tracking controllers, to provide patients with a highly realistic and engaging VRET experience.
  • LimbixVR App: Limbix is anticipated to provide a user-friendly and engaging virtual reality software for exposure treatment. The app might offer a library of immersive and configurable scenarios that mirror real-life circumstances, allowing therapists to construct customised exposure sessions for patients.

Segmentation:

By Component

  • Hardware
  • Software

By Application

  • Anxiety Disorders
  • Post-Traumatic Stress Disorder (Ptsd)
  • Phobias And Specific Fears
  • Panic Disorder
  • Obsessive-Compulsive Disorder (Ocd)
  • Others

By Type

  • Monitoring And Health Tracking
  • Disease Management
  • Remote Consultation And Telemedicine
  • Medication Adherence
  • Fitness And Nutrition
  • Women's Health
  • Others

By End-User

  • Hospitals And Clinics
  • Mental Health Centers
  • Research Institutes
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Sources
  • 2.3. Research Design

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY COMPONENT

  • 5.1. Introduction
  • 5.2. HARDWARE
  • 5.3. SOFTWARE

6. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. ANXIETY DISORDERS
  • 6.3. POST-TRAUMATIC STRESS DISORDER (PTSD)
  • 6.4. PHOBIAS AND SPECIFIC FEARS
  • 6.5. PANIC DISORDER
  • 6.6. OBSESSIVE-COMPULSIVE DISORDER (OCD)
  • 6.7. OTHERS

7. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY TYPE

  • 7.1. Introduction
  • 7.2. MONITORING AND HEALTH TRACKING
  • 7.3. DISEASE MANAGEMENT
  • 7.4. REMOTE CONSULTATION AND TELEMEDICINE
  • 7.5. MEDICATION ADHERENCE
  • 7.6. FITNESS AND NUTRITION
  • 7.7. WOMEN'S HEALTH
  • 7.8. OTHERS

8. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY END-USER

  • 8.1. Introduction
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. MENTAL HEALTH CENTERS
  • 8.4. RESEARCH INSTITUTES
  • 8.5. OTHERS

9. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. United Kingdom
    • 9.4.2. Germany
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. Japan
    • 9.6.2. China
    • 9.6.3. India
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Taiwan
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. VIRTUALLY BETTER, INC.
  • 11.2. LIMBIX INC.
  • 11.3. PSIOUS
  • 11.4. OXFORD VR
  • 11.5. APPLIEDVR, INC.
  • 11.6. VIRTUAL REALITY MEDICAL CENTER
  • 11.7. VIRTUAL REHAB
  • 11.8. BRAVEMIND (DEVELOPED BY USC INSTITUTE FOR CREATIVE TECHNOLOGIES)
  • 11.9. XRHEALTH (FORMERLY KNOWN AS VRHEALTH)
  • 11.10. COGNIFIT